KYRON trial

Advertisement

cGxPJobs Banner

Actio Biosciences Initiates KYRON Phase 1b/2 Trial for KCNT1-Related Epilepsy

SAN DIEGO, May 8, 2026 Actio Biosciences announced the initiation of the KYRON Phase 1b/2 clinical trial evaluating ABS-1230,...

By cGxPwire Editor
May 11, 2026

Read More

Advertisement

cGxPJobs

Directory